Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali Al-Radaideh

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
CNS Neuroscience & Therapeutics|September 30, 2017
Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: Clinical, ophthalmological and radiological assessments of safety and efficacySaid Dahbour, Fatima Jamali, Dana Alhattab, et al.
Beilstein Journal of Nanotechnology|November 1, 2019
Gold-coated plant virus as computed tomography imaging contrast agentAlaa A A Aljabali, Mazhar S Al Zoubi, Khalid M Al-Batanyeh, et al.
Cell Transplantation|March 7, 2024
Human Umbilical Cord-Derived Mesenchymal Stem Cells in the Treatment of Multiple Sclerosis Patients: Phase I/II Dose-Finding Clinical StudyFatima Jamali, Mayis Aldughmi, Serin Atiani, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
CNS Neuroscience & Therapeutics|September 30, 2017
Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: Clinical, ophthalmological and radiological assessments of safety and efficacySaid Dahbour, Fatima Jamali, Dana Alhattab, et al.
Beilstein Journal of Nanotechnology|November 1, 2019
Gold-coated plant virus as computed tomography imaging contrast agentAlaa A A Aljabali, Mazhar S Al Zoubi, Khalid M Al-Batanyeh, et al.
Cell Transplantation|March 7, 2024
Human Umbilical Cord-Derived Mesenchymal Stem Cells in the Treatment of Multiple Sclerosis Patients: Phase I/II Dose-Finding Clinical StudyFatima Jamali, Mayis Aldughmi, Serin Atiani, et al.
Pageof 3